Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R G Mason

Showing results (91-100 of 107) with videos related to

Pageof 11
Sort By:
Transactions - American Society for Artificial Internal Organs|January 1, 1980
Panel conference. Blood surface interactionsR M Lindsay, R G Mason, S W Kim, et al.
Journal of Biomedical Materials Research|November 1, 1974
An in vitro test system for estimation of blood compatibility of biomaterialsR G Mason, R W Shermer, W H Zucker, et al.
The American Journal of Pathology|August 1, 1981
Effects of heparin on platelet aggregation and release and thromboxane A2 productionS F Mohammad, W H Anderson, J B Smith, et al.
Scientific Reports|November 12, 2025
Enhanced stabilisation of soil carbon via arbuscular mycorrhizal fungi and biocharAlexander R G Mason, Bahareh Bicharanloo, Matthias Salomon, et al.
Science (New York, N.Y.)|August 3, 1979
Heparin neutralization of PGI2: effects upon plateletsH I Saba, S R Saba, C A Blackburn, et al.
The American Journal of Pathology|June 1, 1976
Effects of antithrombotic agents evaluated in a nonhuman primate vascular shunt modelR G Mason, R H Wolf, W H Zucker, et al.
Blood|November 1, 1974
Sickle hemoglobin in combination with HbJBangkok (alphaA2beta56-2gly leads to asp)U Gunay, C Pauli, M Shamsuddin, et al.
Blood|April 1, 1980
Two new sickle cell syndromes: HbS, Hb Camden, and alpha-thalassemia; and HbS in combination with Hb TacomaG R Honig, R G Mason, M Shamsuddin, et al.
Biochimica Et Biophysica Acta|December 16, 1980
Hemoglobin Milledgeville (alpha 44 (CD2) Pro leads to Leu): a new variant with increased oxygen affinityG R Honig, L N Vida, M Shamsuddin, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|August 1, 1974
Study of the reactions of blood with artificial surfaces. Use of the thrombogeneratorR G Mason, W H Zucker, B A Shinoda, et al.
Pageof 11

Showing results (91-100 of 107) with videos related to

Sort By:
Pageof 11
Transactions - American Society for Artificial Internal Organs|January 1, 1980
Panel conference. Blood surface interactionsR M Lindsay, R G Mason, S W Kim, et al.
Journal of Biomedical Materials Research|November 1, 1974
An in vitro test system for estimation of blood compatibility of biomaterialsR G Mason, R W Shermer, W H Zucker, et al.
The American Journal of Pathology|August 1, 1981
Effects of heparin on platelet aggregation and release and thromboxane A2 productionS F Mohammad, W H Anderson, J B Smith, et al.
Scientific Reports|November 12, 2025
Enhanced stabilisation of soil carbon via arbuscular mycorrhizal fungi and biocharAlexander R G Mason, Bahareh Bicharanloo, Matthias Salomon, et al.
Science (New York, N.Y.)|August 3, 1979
Heparin neutralization of PGI2: effects upon plateletsH I Saba, S R Saba, C A Blackburn, et al.
The American Journal of Pathology|June 1, 1976
Effects of antithrombotic agents evaluated in a nonhuman primate vascular shunt modelR G Mason, R H Wolf, W H Zucker, et al.
Blood|November 1, 1974
Sickle hemoglobin in combination with HbJBangkok (alphaA2beta56-2gly leads to asp)U Gunay, C Pauli, M Shamsuddin, et al.
Blood|April 1, 1980
Two new sickle cell syndromes: HbS, Hb Camden, and alpha-thalassemia; and HbS in combination with Hb TacomaG R Honig, R G Mason, M Shamsuddin, et al.
Biochimica Et Biophysica Acta|December 16, 1980
Hemoglobin Milledgeville (alpha 44 (CD2) Pro leads to Leu): a new variant with increased oxygen affinityG R Honig, L N Vida, M Shamsuddin, et al.
Laboratory Investigation; a Journal of Technical Methods and Pathology|August 1, 1974
Study of the reactions of blood with artificial surfaces. Use of the thrombogeneratorR G Mason, W H Zucker, B A Shinoda, et al.
Pageof 11